3-Deazaneplanocin A
Code | Size | Price |
---|
TAR-T6292-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T6292-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
3-Deazaneplanocin A (DZNep) is an attractive epigenetic anticancer agent through the inhibition of the cellular enhancer of zeste homolog 2 (EZH2) protein.
CAS:
102052-95-9
Molecular Weight:
262.26
Pathway:
Chromatin/Epigenetic
Purity:
0.98
SMILES:
C1=CN=C(C2=C1N(C=N2)[C@@H]3C=C([C@H]([C@H]3O)O)CO)N
Target:
Histone Methyltransferase
References
Avan A, et al. Mol Cancer Ther. 2012 Aug;11(8):1735-46.
Kikuchi J, et al. Lung Cancer. 2012 Nov;78(2):138-43.